Cytomegalovirus Infection after CD34(+) Selected Hematopoietic Cell Transplant

BACKGROUND: The effectiveness of preemptive treatment (PET) for CMV in recipients of ex vivo T-cell depleted (TCD) hematopoietic cell transplantation (HCT) by CD34(+) selection is not well defined. METHODS: We analyzed 213 adults who received TCD-HCT at our institution from June 2010 through May 201...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biol Blood Marrow Transplant
Auteurs principaux: Huang, Yao-Ting, Neofytos, Dionysios, Foldi, Julia, Kim, Seong Jin, Maloy, Molly, Chung, Dick, Castro-Malaspina, Hugo, Giralt, Sergio A., Papadopoulos, Esperanza, Perales, Miguel-Angel, Jakubowski, Ann A., Papanicolaou, Genovefa A.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4949094/
https://ncbi.nlm.nih.gov/pubmed/27178374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.05.003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires